top of page

Search


C15:0 (Pentadecanoic Acid): Could This Be the First Newly Recognized Essential Fatty Acid in Nearly 100 Years?
Could C15:0 (pentadecanoic acid) become the first newly recognized essential fatty acid in nearly a century? Emerging research suggests this naturally occurring odd-chain saturated fatty acid may support healthy cell membranes, mitochondrial function, metabolic health, and healthy aging. Learn what current science tells us about food sources, supplements, recommended intake, and why researchers are paying close attention to this unique nutrient.

David Stephen Klein, MD FACA FACPM
Aug 77 min read


Pre-Diabetes: Insulin Resistance, Is It a Real Condition — Or a Warning Sign We Ignore at Our Own Risk?
Many people are told they have pre-diabetes and assume it simply means they may someday develop diabetes.
The truth is far more concerning.
Long before someone officially develops Type 2 diabetes, elevated insulin levels and subtle abnormalities in blood sugar regulation may already be damaging blood vessels, nerves, kidneys, and even the brain.
Prediabetes is not almost disease.
It is often the earliest measurable sign that metabolic dysfunction has already begun.
The g

David Stephen Klein, MD FACA FACPM
Jul 36 min read


Vyepti® for Migraine Prevention: IV Treatment, Benefits, Risks, and Insurance Steps
Vyepti® (eptinezumab) is a quarterly intravenous treatment designed to prevent migraines before they begin. Unlike daily medications or monthly injections, Vyepti is administered only four times per year and targets CGRP, a key migraine signaling molecule. Learn how this innovative therapy works, who may qualify, what side effects to consider, and the insurance steps often required before treatment can begin. This guide reviews the benefits, risks, and practical consideration

David Stephen Klein, MD FACA FACPM
Jun 125 min read


Lower Your Serum Insulin Level to Reduce the Risk of Cancer, Diabetes, and Live Longer.
Lower Your Serum Insulin Level to Reduce the Risk of Cancer, Diabetes, and Live Longer

David S. Klein, MD FACA FACPM
Oct 1, 20257 min read


GLP-1 Medications and Dementia Prevention. Weight Loss, Diabetes Risk Reduction and Alzheimer's Prevention, as a Bonus!
Popular GLP-1 medications, like Ozempic and Zepbound may provide prevention of Alzheimer's Dementia on top of the weight reduction and diabetes control.
Reduction of weight helps with Sleep Apnea, as well. Understand the need for medical monitoring if you are going to use these medications.
This is a worthy read to give a comprehensive presentation as to the risks/benefits as well as the need for vigilance.

David S. Klein, MD FACA FACPM
Sep 23, 202512 min read


Insulin Level and the Risk of Cancer, Diabetes: Berberine may be the Answer by Lowering Insulin while Lowering Glucose.
Lowering insulin while lowering blood sugar is achievable with a thoughtful combination of over the counter products.

David S. Klein, MD FACA FACPM
Sep 9, 20254 min read
bottom of page
